483 Takeda Pharmaceutical Company Sep 2013

483 Takeda Pharmaceutical Company Sep 2013

Xiaokuang Lai FDA, Nicholas Violand FDA$119.00 - Available Now

FDA investigators audited the Takeda Pharmaceutical Company - Osaka, Japan facility and issued 5 inspectional observations (via FDA 483) on 06 Sep 2013.

Product details

  • Category: Human Drugs
  • Number of Observations: 5
  • Inspection end: 06 Sep 2013
  • Location: Osaka, Japan
  • FEI: 3002808311
Add To Cart